JIMRT Journal

Announcements

  • Peer Review Policy
    Ijcope follows Strict Peer Review Policy
  • Guidelines
    IARJET follows double-blind peer review process to ensure high quality of Guidelines
  • ISSN IS: 2583-0813
    An International Open Access, Peer Reviewed Journal
  • Call for Papers
    July 2025. Ijcop invites all research papers for publication in Volume 4, Issue 4
  • Peer Review Policy
    Ijcope follows Strict Peer Review Policy
  • Guidelines
    IARJET follows double-blind peer review process to ensure high quality of Guidelines
  • ISSN IS: 2583-0813
    An International Open Access, Peer Reviewed Journal
  • Call for Papers
    July 2025. Ijcop invites all research papers for publication in Volume 4, Issue 4
Announcements
Journal Cover Page

Submit Your Article Now

Molecular and Cellular Characterization of Disease‑Associated Biomarkers Using Advanced Laboratory Techniques

 

Priyanka Menon, Dr. Nisha Gupta
Department of Biotechnology, University Institute of Biotechnology (UIBT),

Chandigarh University, Mohali, Punjab 140413, India

 

 Abstract

Molecular and cellular profiling of disease-related biomarkers has become a cornerstone in modern biomedical research and clinical diagnostics. Biomarkers provide critical insights into disease mechanisms, prognosis, and therapeutic responses. Their discovery and analysis rely on cutting-edge laboratory techniques, such as nucleic acid amplification methods like PCR and digital PCR, high-throughput sequencing, proteomics, single-cell assays, and advanced imaging technologies. This article explores the principles, applications, and challenges of contemporary molecular and cellular techniques for characterizing biomarkers associated with diseases. We gather current knowledge from genomics, proteomics, transcriptomics, and multiomics strategies, highlighting how these methods facilitate early detection and personalized medicine, and propose practical frameworks for integrating these tools into diagnostics and research. Case studies from oncology and infectious diseases illustrate their practical use. We also examine future directions in biomarker discovery, including microfluidic platforms and multimodal computational methods that integrate complex datasets. Finally, we emphasize the importance of standardized protocols and ethical considerations in clinical translation. These advancements have significantly improved the sensitivity and specificity of biomarker detection, enabling more accurate disease classification and monitoring. However, challenges remain in data integration, reproducibility, and translating laboratory findings into clinical practice. Addressing these challenges requires interdisciplinary collaboration and the development of robust computational tools to handle the complexity of multiomics data.

 Keywords

Molecular profiling, Biomarkers, Cellular profiling, Proteomics, Single-cell analysis, Next-generation sequencing, Liquid biopsy, High-throughput technologies, Precision medicine

Call for Papers
Volume 02 Issue 06 June 2026
Submission
Last Date
30/06/2026
Acceptance
Status
within 10 Days
Paper Publish within 5 Days
Scroll to Top